Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 140

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 140
---
    — |
| 12/2041         |     | $            |    0.3 |     | $            |    0.3 |     |           |    — |
| 12/2042         |     |              |      — |     | $            |    0.1 |     |           |    — |
| 12/2043         |     |              |      — |     |              |      — |     |           |    — |
| 12/2044         |     |              |      — |     |              |      — |     |           |    — |
| Total           |     | $            | 227.20 |     | $            | 208.20 |     | $         | 19.7 |

| (1) | Tax Receivables Benefits forecast to be realized by Enfusion. |

| (2) | Portion of Tax Receivables Benefit forecast to be paid by Enfusion to TRA Holders pursuant to the TRA, 
 calculated as provided under the TRA (using certain assumptions).                                      |

The Management Projections were developed by Enfusion management as then-current estimates of Enfusion’s future financial performance as an independent company, without giving effect to the Transactions or any changes to Enfusion’s operations or strategy that may be implemented in connection with the pendency of, or following the consummation of, the Transactions. The Management Projections also do not consider the effect of any failure of the Transactions to be completed, and it should not be viewed as accurate or continuing in that context. The Management Projections do not take into account any circumstances, transactions or events occurring after the date on which the Management Projections were prepared and do not give effect to any changes after the date on which they were made, including as a result of the Transactions or any effects of the Transactions. The Management Projections were not prepared with a view toward public disclosure or complying with GAAP, published guidelines of the SEC or the guidelines established by the American Institute of Certified Public Accountants for preparation or presentation of prospective financial information. The Management Projections included in this document have been prepared by, and are the responsibility of, Enfusion’s management. Neither Enfusion’s independent auditor nor any other independent accountants have audited, reviewed, examined, compiled nor applied agreed-upon procedures with respect to the Management Projections, 88

nor have they expressed an opinion or any other form of assurance on such information or its